Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPennant International Regulatory News (PEN)

Share Price Information for Pennant International (PEN)

Share Price is delayed by 15 minutes
Get Live Data
23.50    0.00 (0.00%)
Bid:
23.00
Ask:
24.00
Spread: 1.00 (4.348%)
Market Cap: £11.19m
PEN Live PriceLast checked at - London Stock Exchange

Intraday Pennant International Share Chart

Share Option Restructuring

9 Nov 2022 07:00

RNS Number : 7472F
Pennant International Group PLC
09 November 2022
 

 

FOR IMMEDIATE RELEASE 09 November 2022

PENNANT INTERNATIONAL GROUP PLC

 

Director/PDMR Shareholding

Share Option Restructuring

 

 

Pennant International Group plc (AIM: PEN) (the "Company"), announces the restructuring of the share options held by the executive directors, Philip Walker and David Clements.

 

Mr Walker has surrendered an EMI option over 297,619 unissued ordinary shares of 5p each in the capital of the Company ("ordinary shares") exercisable at 84p per share and an unapproved option over 525,969 unissued ordinary shares exercisable at 55p per share. Mr Clements has surrendered EMI options over 100,000 unissued ordinary shares exercisable at 80.5p and 205,455 unissued ordinary shares exercisable at 82.5p per share.

 

Following consultation with major shareholders, the Company has granted to Mr Walker a new EMI option over 500,000 unissued ordinary shares, and Mr Clements has been granted a new EMI option over 300,000 unissued ordinary shares (the "New Options"). The New Options are the only options (or other rights to acquire shares in the Company) held by the executive directors.

The New Options are subject to vesting conditions tied to achieving growth in the Company's share price, vesting in 20% tranches as and when certain milestones are achieved and the share price sustained at that level for at least 30 days, as follows:

 

Target share price

 

% of New Options vesting

 

 

57p

20%

62p

20%

67p

20%

72p

20%

77p

20%

 

In order for the New Options to vest, these targets must be achieved during the three years following the date of grant (the "Performance Period") and to the extent that the New Options have not vested during the Performance Period, the rights over the unissued shares will lapse. Any shares that are acquired pursuant to exercise of the New Options must be held by the relevant executive director for at least the Performance Period. The exercise price under the New Options is 33.5p per share.

 

The New Options are subject to further conditions contained in the Company's EMI scheme document, as approved by shareholder vote in 2019. Each executive director's New Options lapse should his employment cease.

The tables below provide further details for each PDMR.

 

 

 

 

Enquiries:

 

Pennant International Group plc

www.pennantplc.co.uk

Philip Walker, CEO

David Clements, Commercial & Risk Director 

+44 (0) 1452 714 914

WH Ireland Limited (Nomad and Broker)

 https://www.whirelandplc.com/capital-markets

Mike Coe

Sarah Mather

+44 (0) 20 7220 1666

Walbrook PR (Financial PR)

paul.vann@walbrookpr.com

Paul Vann

Tom Cooper

+44 (0)20 7933 8780

Mob: +44 (0)7768 807631

 

 

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Philip Walker

2

 

Reason for the notification

 

a)

 

Position/status

Chief Executive Officer

b)

 

Initial notification /Amendment

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

Pennant International Group plc

b)

 

LEI

2138005AIIUYSRP5O254

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of 5p each

Identification code

GB0002570660

b)

 

Nature of the transaction

Option award 

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

Award of shares

£0.335

500,000

d)

 

Aggregated information

Award of shares

- Aggregated volume

500,000

- Price

£167,500

e)

 

Date of the transaction

 

8 November 2022

f)

 

Place of the transaction

Outside a trading venue

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

David Clements

2

 

Reason for the notification

 

a)

 

Position/status

Commercial & Risk Director

b)

 

Initial notification /Amendment

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

Pennant International Group plc

b)

 

LEI

2138005AIIUYSRP5O254

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of 5p each

Identification code

GB0002570660

b)

 

Nature of the transaction

Option award 

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

Award of shares

£0.335

300,000

d)

 

Aggregated information

Award of shares

- Aggregated volume

300,000

- Price

£100,500

e)

 

Date of the transaction

 

8 November 2022

f)

 

Place of the transaction

Outside a trading venue

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFVTLILTIIF
Date   Source Headline
15th Aug 20168:20 amRNSDirector/PDMR Shareholding
15th Aug 20167:00 amRNSPlacing of £3.56m
19th Jul 20167:00 amRNSRecord Order Book drives expansion of premises
15th Jul 20169:30 amRNSHoldings in Company
14th Jul 201610:55 amRNSHolding(s) in Company
14th Jul 20167:00 amRNSDirector Dealing
20th Jun 201612:05 pmRNSGrant of Options
16th Jun 20167:00 amRNSNew Contract Award and Trading Update
1st Jun 20167:14 amRNSNew Contract Awards worth in excess of £13 million
18th May 201612:00 pmRNSDirectorate Change
20th Apr 201611:17 amRNSResult of AGM and GM
19th Apr 20167:00 amRNSDirectorate Change
23rd Mar 20167:00 amRNSDocuments available on the Company's website
7th Mar 20167:00 amRNS2015 Final Results
3rd Mar 201611:00 amRNSDirectorate Change
5th Feb 20167:00 amRNSNew Contract Award & Notice of 2015 Final Results
11th Dec 20157:00 amRNSTrading Update
17th Nov 20157:00 amRNSDirectorate Change
19th Oct 20151:40 pmRNSDirector/PDMR Shareholding
5th Oct 20157:00 amRNSDirector Incentivisation
28th Sep 20157:00 amRNSNew £7million Contract Award
28th Sep 20157:00 amRNS2015 Interim Results
18th Sep 201512:00 pmRNSNotice of Results
26th Aug 20152:47 pmRNSHolding(s) in Company
14th Apr 201511:12 amRNSResult of AGM and GM
8th Apr 20152:30 pmRNSDirector/PDMR Shareholding
17th Mar 201512:00 pmRNSDocuments available on the Company's website
17th Mar 20159:55 amRNSDocuments available on the Company's website
17th Mar 20157:00 amRNS2014 Final Results
6th Mar 20157:00 amRNSNotice of Final Results
22nd Jan 20157:00 amRNSPre-close Trading Update
10th Nov 201412:00 pmRNSTransaction in Own Shares
22nd Sep 20147:00 amRNSDirectorate Change
17th Sep 20147:00 amRNSContract win
8th Sep 20147:00 amRNSHalf Yearly Report
1st Sep 201411:35 amRNSNotice of Results
15th Jul 20144:29 pmRNSDirector/PDMR Shareholding
24th Jun 20144:36 pmRNSDirector Dealing
6th Jun 20145:17 pmRNSDirector/PDMR Shareholding
29th Apr 20144:20 pmRNSDirector Incentivisation
10th Apr 20143:39 pmRNSResult of Meeting
12th Mar 20147:00 amRNSDirectorate Change
10th Mar 20147:00 amRNSFinal Results
10th Feb 20143:45 pmRNSHolding(s) in Company
3rd Feb 20142:14 pmRNSHolding(s) in Company
3rd Feb 20142:00 pmRNSHolding(s) in Company
9th Dec 20134:15 pmRNSHolding(s) in Company
14th Nov 201311:10 amRNSNotification of Major Interest of Shares
21st Oct 201311:03 amRNSDirector/PDMR Shareholding
5th Aug 20137:00 amRNSHalf Yearly Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.